Grange P A, Erickson A K, Levery S B, Francis D H
Department of Veterinary Science, South Dakota State University, Brookings 57007, USA.
Infect Immun. 1999 Jan;67(1):165-72. doi: 10.1128/IAI.67.1.165-172.1999.
In this study, we identified a receptor for the K88ad fimbrial adhesin of Escherichia coli in neutral glycosphingolipid preparations from intestinal epithelial cells of K88ad-adhesive pigs, which was absent in preparations from K88ad-nonadhesive pigs. Neither K88ab nor K88ac adhesin variants bound to this neutral glycosphingolipid. Because this receptor is an intestinal glycosphingolipid that binds K88ad adhesin, it has been designated IGLad. Carbohydrate compositional analysis of a partially purified preparation of IGLad identified galactose, glucose, and N-acetylglucosamine in a ratio of 1.5:1.0:0.5 as the major monosaccharides. Preliminary characterization experiments using lectins showed that IGLad contains the terminal glycanic structure Galbeta1-4GlcNAc. Removal of terminal beta-linked galactose residues from IGLad decreased the recognition of IGLad by the K88ad adhesin, indicating that terminal beta-linked galactose is an essential component of the K88ad adhesin recognition site on IGLad. Studies with purified glycosphingolipid standards demonstrated that K88ad adhesin binds to neolactotetraosylceramide (nLc4Cer) (Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta1-1Cer) , lactotriosylceramide (GlcNAcbeta1-3Galbeta1-4Glcbeta1-1Cer) and lactotetraosylceramide (Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta1-1Cer) . Based on these studies, IGLad appears to be nLc4Cer.
在本研究中,我们在来自K88ad黏附性猪肠道上皮细胞的中性糖鞘脂制剂中鉴定出一种大肠杆菌K88ad菌毛黏附素的受体,而在来自K88ad非黏附性猪的制剂中则不存在该受体。K88ab和K88ac黏附素变体均不与这种中性糖鞘脂结合。由于该受体是一种能结合K88ad黏附素的肠道糖鞘脂,因此被命名为IGLad。对IGLad部分纯化制剂的碳水化合物组成分析确定,半乳糖、葡萄糖和N - 乙酰葡糖胺的比例为1.5:1.0:0.5是主要的单糖。使用凝集素进行的初步表征实验表明,IGLad含有末端聚糖结构Galβ1-4GlcNAc。从IGLad上去除末端β连接的半乳糖残基会降低K88ad黏附素对IGLad的识别,这表明末端β连接的半乳糖是IGLad上K88ad黏附素识别位点的重要组成部分。对纯化的糖鞘脂标准品的研究表明,K88ad黏附素与新乳糖四糖神经酰胺(nLc4Cer)(Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ1-1Cer)、乳糖三糖神经酰胺(GlcNAcβ1-3Galβ1-4Glcβ1-1Cer)和乳糖四糖神经酰胺(Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ1-1Cer)结合。基于这些研究,IGLad似乎是nLc4Cer。